Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial

por Michiko Asano, Hiroshi Okada, Yohji Itoh, Hajime Hirata, Kensuke Ishikawa, Erika Yoshida, Akiko Matsui, Elizabeth J. Kelly, Kathryn Shoemaker, Urban Olsson, Johan Vekemans
Publicado 2022

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.

por Daniel Ansong, Kwaku P Asante, Johan Vekemans, Sandra K Owusu, Ruth Owusu, Naana A W Brobby, David Dosoo, Alex Osei-Akoto, Kingsley Osei-Kwakye, Emmanuel Asafo-Adjei, Kwadwo O Boahen, Justice Sylverken, George Adjei, David Sambian, Stephen Apanga, Kingsley Kayan, Michel H Janssens, Marc J J Lievens, Aurelie C Olivier, Erik Jongert, Patrice Dubois, Barbara M Savarese, Joe Cohen, Sampson Antwi, Brian M Greenwood, Jennifer A Evans, Tsiri Agbenyega, Philippe J Moris, Seth Owusu-Agyei
Publicado 2011